1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsNERVE Program (Neurotech Entrepreneurship to Validate Emerging Innovations) is sponsored by Ontario Brain Institute (OBI). The NERVE Program supports early-stage entrepreneurs based in Canada who are building neurotech ventures.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Neurotech Entrepreneurship to Validate… | Ontario Brain Institute Neurotech Entrepreneurship to Validate Emerging Innovations (NERVE) $100,000 to build your neurotechnology venture The NERVE (Neurotech Entrepreneurship to Validate Emerging Innovations) program is Canada's single largest award that catalyzes early stage entrepreneurs to commercialize brain-related technologies by accessing funding and support to launch or grow their neurotechnology ventures.
Applications for the 2026 NERVE Program are now closed. Up to 5 entrepreneurs are awarded annually for the 12-month program Non-dilutive grant.
OBI does not take equity or IP Workshops and training opportunities to build your venture 1:1 mentorship from an expert in your sector Value-add opportunities as part of our network From Discovery to Impact: The NERVE Program As Canada’s largest award for early-stage neurotech ventures, NERVE provides $100,000 in funding, 12 months of training, one-on-one mentorship, and commercialization support to help Canadian entrepreneurs launch and grow their brain-related technologies.
Ontario Brain Institute's NERVE (Neurotech Entrepreneurship to Validate Emerging Innovations) Program The NERVE Program is fueling the growth of the neurotech cluster.
HeadFirst, an OBI portfolio company featured for breakthrough saliva-based concussion test HeadFirst, a University of Waterloo startup that joined the OBI portfolio through the 2025 NERVE program , has been featured by the university for its innovative work developing a saliva-based concussion detection device.
The medical device, currently in development, detects concussion-related biomarkers that appear in saliva following a head injury. This technology aims to remove the guesswork from concussion screening by providing objective diagnostic tools where they're needed most: athletic departments, sports organizations, healthcare facilities, and beyond.
Trexo is a game-changer for children with cerebral palsy Trexo Robotics, an Ontario Brain Institute portfolio company, creates mobility devices that help children with disabilities remain upright for longer periods and repeat movements to learn how to walk with a healthy gait pattern. The Trexo gait trainer is a long-awaited dream come true for many families.
These types of interventions are invaluable - not only has Griffin's mobility improved but his independence and curiosity have as well. NeuroQore’s First Dawn – A Solution for Treatment-Resistant Depression As a teenager, Mehran Talebinejad, Co-Founder & CEO of NeuroQore, got interested in understanding the brain, and particularly depression, for one reason alone – his grandma.
He wanted to offer help for her depression but due to a lack of care services and delays in finding the right drug treatment, coupled with the stigma associated with depression, he was unable to support her in the way he wanted. It was in that moment that he decided to take matters into his own hands – someone had to fundamentally transform mental health treatments – and it had to be him.
Bringing New Technology to Life - A Giant Leap for Elder Care In the most rewarding relationships, everyone brings something to the table. When OBI partners with other organizations, we consider the ways each party can be of value to a mutually shared goal. The Welbi platform is a perfect example.
The innovation of an innovative Ottawa startup, Welbi helps senior living communities reduce social isolation, and acts as a personal assistant automating administrative tasks, providing alerts and making recommendations to staff so that they can better tailor their services to the needs of their community.
Epineuron Technologies Closes Financing for its Breakthrough Nerve Regeneration Device Epineuron Technologies, Inc., a bioelectronic medicine company, announced the completion of a financing round to support production development and clinical validation for its neuroregenerative technology - designated a breakthrough device by the FDA.
HeadFirst, an OBI portfolio company featured for breakthrough saliva-based concussion test HeadFirst, a University of Waterloo startup that joined the OBI portfolio through the 2025 NERVE program , has been featured by the university for its innovative work developing a saliva-based concussion detection device.
The medical device, currently in development, detects concussion-related biomarkers that appear in saliva following a head injury. This technology aims to remove the guesswork from concussion screening by providing objective diagnostic tools where they're needed most: athletic departments, sports organizations, healthcare facilities, and beyond.
Private and institutional investors interested in learning more about the neurotech industry or considering investments in this space can gain access to OBI’s investor platform with detailed profiles of OBI’s portfolio companies . To learn more, please contact us at BD&P@braininstitute. ca .
If you are commercializing a neurotechnology we want to hear from you. Email us at BD&P@braininstitute. ca to hear more about the neurotech industry and OBI’s commercialization programs and opportunities.
Help us bring brain health to life.
According to the current listing, eligibility includes: Early-stage entrepreneurs based in Canada who commit to being full-time entrepreneurs during the program. Applicants must have an incorporated neurotech company or plans to incorporate one in Canada. Confirm the full requirements in the official notice before applying.
The current listing shows $100,000 in non-dilutive funding. Verify award ceilings, matching requirements, and allowable costs in the official notice.
NERVE Program (Neurotech Entrepreneurship to Validate Emerging Innovations) is funded by Ontario Brain Institute (OBI). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
ARPA-H's HEARING program (ARPA-H-SOL-26-154) — Hearing Enhancement through ARtificially Intelligent NeurotechnoloGy — held its Proposers' Day on June 8, 2026 and set Solution Summary deadlines for June 29 with Full Proposals due August 14. Single prime awardee, multiple Other Transaction Agreements, three integrated technical areas spanning intracortical recording and stimulation devices, wearable dynamic sound modulators, and AI-based auditory read/write algorithms. The first phase runs 18 months; the full effort runs 4.5 years through first-in-human clinical studies. For neurotech teams that have spent a decade in cochlear-implant or visual-prosthesis space, this is the moment the federal government bet on auditory cortex over the cochlea.
Read articleA Nature poll finds three-quarters of American scientists are considering working abroad. ERC applications from U.S. researchers have tripled. France and the EU pledged €500 million to recruit them. Inside the brain drain reshaping global science — and what it means for grant strategy.
Read article